STEPHEN ROCAMBOLI - 15 Aug 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
Director
Signature
/s/ Stephen Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
TFFP
Transactions as of
15 Aug 2023
Transactions value $
$5,000
Form type
4
Filing time
15 Aug 2023, 09:00:16 UTC
Previous filing
16 Jun 2023
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Purchase $5,000 +20,000 +125% $0.2500 36,000 15 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.